Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macitentan for Pulmonary Hypertension in Sickle Cell Disease
NCT02651272Phase 2Terminated
- Sponsor
- Boston University
- Start
- Jul 2015
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of macitentan in pulmonary hypertension (PH), sponsored by Boston University. Started Jul 2015; status: terminated.
02
Drugs
macitentan
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT02651272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02651272.